ANAB vs AUPH Stock Comparison

AUPH currently leads ANAB in this stock comparison, with AIQ scores of 75 vs 56. The clearest difference is momentum.

Market data as of Nov 15, 2026 market close· AIQ score gap 19 points
ANAB
Healthcare
vs
AUPH
Healthcare
ANAB
AnaptysBio, Inc.
Price
$46.25
Day move
-3.18%
AIQ Score
56/100
Best edge
Balanced
Sector
Healthcare
AUPH
Aurinia Pharmaceuticals Inc.
Leads
Price
$15.73
Day move
-2.96%
AIQ Score
75/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between ANAB and AUPH?

AUPH leads the current stock comparison as Aurinia Pharmaceuticals Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

AnaptysBio, Inc. vs Aurinia Pharmaceuticals Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 8/10

AUPH leads

AUPH leads by 19 AIQ points, primarily on Momentum and Risk Resilience. Wall Street currently favors ANAB on target upside.

Competitive: 4 of 6 evidence groups support AUPH, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Stable
ANAB

AnaptysBio, Inc.

AIQ Score
56/100
AIQ Edge Score
5/10
AUPH

Aurinia Pharmaceuticals Inc.

Leads
AIQ Score
75/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors AUPH over ANAB, 75 versus 56 as of Nov 15, 2026. AUPH's advantage is driven primarily by stronger momentum and risk resilience. AUPH also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors ANAB. 4 of 6 covered evidence groups favor AUPH today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. AUPH lead: Stable — the AIQ differential has held near 19 points over 30 sessions. AUPH leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.

Compare AnaptysBio, Inc. and Aurinia Pharmaceuticals Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

ANAB
+45.6%
AUPH
-46.1%

Price return comparison

Growth of $10,000, price only

ANAB $14,558 · AUPH $5,387

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare ANAB and AUPH against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ANAB advantage
0
AUPH advantage
  • Momentum36 vs 73
    AUPH +37
  • Risk Resilience46 vs 68
    AUPH +22
  • Value74 vs 84
    AUPH +10
  • Quality72 vs 77
    AUPH +5

4 of 6 evidence groups favor AUPH. AUPH’s edge is concentrated in momentum and risk resilience.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ANAB-1 AIQ

Largest factor move: Value -3

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Distribution Pattern — bearish, volume, medium horizon (1.22x)
AUPH0 AIQ

Largest factor move: Value +1, not enough on its own to move the overall score.

New signals

  • Price Lost 200-Day MA — bearish, trend, long horizon
  • BB Lower Band Breach — bullish, volatility, short horizon

AUPH's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — ANAB and AUPH both carry a full feed there.

The central trade-off

AUPH (Aurinia Pharmaceuticals Inc.): the stronger current systematic profile, led by momentum and risk resilience.

ANAB (AnaptysBio, Inc.): the counter-case, on analyst expectations — but at materially higher volatility, 51.8% against 36.7%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

AUPH

AUPH on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

AUPH

AUPH on combined revenue and EPS growth.

Value

AUPH

AUPH on the peer-relative Value factor, by 10 points.

Momentum

AUPH

AUPH on the Momentum factor, by 37 points.

Lower downside

AUPH

AUPH on Risk Resilience, by 22 points.

Analyst upside

ANAB

ANAB on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors AUPH, analyst targets favor ANAB. That disagreement is the most useful thing on this page.

MeasureANABAUPHNote
Implied upside to target+75.1%+14.4%ANAB has more room
Target dispersion+30.9%0%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering87Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor AUPH. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreAUPH56 vs 75
FundamentalsEvenEPS growth -97.9% vs -17.2%; TTM ROE 18.6% vs 4.8%; gross margin 143.7% vs 90.7%; operating margin 34.6% vs 48.6%
ValuationAUPHValue 74 vs 84
TechnicalsAUPHPrice vs 50-day -7.1% vs -4.6%; vs 200-day -18.1% vs 0%
Risk ResilienceAUPHRisk Resilience 46 vs 68
Analyst expectationsANABTarget upside 75.1% vs 14.4%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ANAB and AUPH and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 19 points. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AUPH.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

AUPH lead: Stable — the AIQ differential has held near 19 points over 30 sessions.

May 27ANAB leads above the line · AUPH leads belowNov 13
Today
AUPH +19
56 vs 75
7 sessions ago
AUPH +19
57 vs 76
30 sessions ago
AUPH +20
53 vs 73
90 sessions ago
AUPH +9
59 vs 68

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ANAB

0 bullish / 3 bearish / 2 neutral

Only ANAB

  • Death Cross Active — bearish, trend, long horizon (13.48%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.60%)
  • Distribution Pattern — bearish, volume, medium horizon (1.22x)
  • Downtrend Structure Active — bearish, trend, long horizon
AUPHConflicted

2 bullish / 2 bearish, conflicted

Only AUPH

  • Golden Cross Active — bullish, trend, long horizon (4.77%)
  • Price Lost 200-Day MA — bearish, trend, long horizon
  • BB Lower Band Breach — bullish, volatility, short horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon

AUPH leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ANABConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -3.18%, AIQ -1 points).

AUPHNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.96%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1ANAB closes the Momentum gap — currently 37 points behind, the largest single contributor to AUPH's edge.
  2. 2ANAB's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3AUPH's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricANABAUPH
Revenue growth (YoY)10.1%0.6%
EPS growth (YoY)-97.9%-17.2%
Gross margin143.7%90.7%
Operating margin34.6%48.6%
Return on equity (TTM)18.6%4.8%
Debt to equity0.60.09

Performance

Split across windows
MetricANABAUPH
1 week (5 sessions)-0.4%-4.4%
1 month (20 sessions)-0.8%-4.7%
3 months (63 sessions)-22.5%2.9%
6 months (126 sessions)-26.8%2.9%
Year to date-4.6%-1.4%
1 year (252 sessions)39.8%1.2%

Technicals

AUPH has the stronger structure
MetricANABAUPH
RSI (14)42.739.9
ADX (14)23.717.3
Price vs 50-day-7.1%-4.6%
Price vs 200-day-18.1%0%
Volatility (1M, annualized)51.8%36.7%

Risk

AUPH is the more resilient
MetricANABAUPH
Beta1.110.64
Sharpe ratio0.780.16
Sortino ratio1.110.23
Max drawdown-35.3%-21.8%
Current drawdown-34.1%-15.5%
Annualized volatility64.8%35.5%
Value at risk (95%)-5.3%-3.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ANAB or AUPH?

On the Algovestiq AIQ Score, AUPH is the stronger of the two as of Nov 15, 2026, scoring 75 against ANAB's 56. The edge comes from momentum and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ANAB or AUPH the better buy right now?

AUPH carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor AUPH over ANAB?

The composite weights Quality, Value, Momentum and Risk Resilience. AUPH leads Momentum by 37 points; AUPH leads Risk Resilience by 22 points; AUPH leads Value by 10 points. AUPH leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by ANAB simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.

Which has more analyst upside, ANAB or AUPH?

Analyst price targets imply +75.1% upside for ANAB and +14.4% for AUPH, so the Street currently favors ANAB. That points the opposite way to the AIQ Score, which favors AUPH. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ANAB or AUPH?

AUPH is the better-valued of the two on the peer-relative Value factor. AUPH on the peer-relative Value factor, by 10 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ANAB or AUPH?

AUPH on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ANAB or AUPH?

AUPH on the Momentum factor, by 37 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ANAB or AUPH?

AUPH is the more resilient of the two, so the other name carries the higher downside risk. AUPH on Risk Resilience, by 22 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ANAB more profitable than AUPH?

The profitability evidence is mixed: gross margin 143.7% vs 90.7%; operating margin 34.6% vs 48.6%; ttm roe 18.6% vs 4.8%. ANAB leads on two measures and AUPH on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is AUPH's lead over ANAB getting stronger or weaker?

AUPH lead: Stable — the AIQ differential has held near 19 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the ANAB vs AUPH verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ANAB closes the Momentum gap — currently 37 points behind, the largest single contributor to AUPH's edge; ANAB's Death Cross Active resolves — a bearish trend rule currently active against it; AUPH's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ANAB and AUPH?

ANAB: 0 bullish / 3 bearish / 2 neutral. AUPH: 2 bullish / 2 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ANAB is Death Cross Active (bearish, long horizon). On AUPH it is Golden Cross Active (bullish, long horizon).

Compare ANAB and AUPH with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.